Search > Epilepsy
60 Participants NeededMy employer runs this trial

SPN-817 for Epilepsy

Recruiting at 8 trial locations
JP
NS
NM
SC
Overseen BySupernus Clinical Trials
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Supernus Pharmaceuticals, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures

Who Is on the Research Team?

MG

Maciej Gasior, MD, PhD

Principal Investigator

Supernus Pharmaceuticals

Are You a Good Fit for This Trial?

Inclusion Criteria

Is able to swallow capsules whole without crushing, chewing, or cutting.
Ability to keep accurate seizure diaries (with the aid of a caregiver as needed).
Weight within the normal or overweight ranges according to accepted values of the Body Mass Index Chart (18.0 to 35 kg/m2).
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • SPN-817

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Open-Label TreatmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Supernus Pharmaceuticals, Inc.

Lead Sponsor

Trials
49
Recruited
14,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.